SMN1 crRNA-wt was able to discriminate SMA patients from normal individuals to some extent, but nonspecific activation of the Cas12a/SMN1 crRNA-wt complex by SMN2 in SMA patients still occurs. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.